Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study
Manik Garg, Dominique‐Laurent Couturier, Jérémie Nsengimana, Nuno A. Fonseca, Matthew J. Wongchenko, Yibing Yan, Martin Lauss, Goran B Jönsson, Julia Newton‐Bishop, Christine Parkinson, Mark Ross Middleton, David Timothy Bishop, Sarah McDonald, Nikki Stefanos, John A. Tadross, , Roy Rabbie
This paper develops a gene expression signature, Cam_121, to predict long-term outcomes in primary melanoma patients, showing improved accuracy compared to clinical and existing prognostic models.
Nature Communications · Feb 18, 2021Peer-reviewedBioinformatics